Q32 Bio Inc.
QTTBBiotechnology
$8.87−2.10%As of Oct 29vs prior close
- Market cap
- $264.1M
- P/E (TTM)
- 3.7×
- From 52W high
- −58.51%
- EPS (LTM)
- $2.42
- Revenue (LTM)
- $53.7M
- Net margin
- 55.49%
- Dividend yield
- 0.00%
Nomior Score
61
Steady ProfileTop 25% of the scored universe
Growth—
Quality63
Value—
Momentum87
Resilience34
Growth
+39.14%revenue a year over 7 fiscal years
YE18 $5.3MLTM $53.7M
Connections
Revenue to profitQ3 YE23
The operating loss was 419% of revenue, narrower by 3678 pts on a year.
Who owns it
1fund